RBX1 and ovarian cancer: Silencing of the CRL4 E3 ubiquitin ligase complex ROC1 and CUL4A genes by siRNA significantly decreased the expression of CFP1 and BST2, consistent with that observed after MLN4924 treatment of ovarian cancer cells.